rxo inc - RXO
RXO
Close Chg Chg %
12.71 -0.13 -0.98%
Open Market
12.58
-0.13 (0.98%)
Volume: 519.40K
Last Updated:
Dec 31, 2025, 1:08 PM EDT
Company Overview: rxo inc - RXO
RXO Key Data
| Open $12.73 | Day Range 12.53 - 12.73 |
| 52 Week Range 10.43 - 26.92 | Market Cap $2.08B |
| Shares Outstanding 164.11M | Public Float 160.72M |
| Beta 1.61 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.44 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.02M |
RXO Performance
| 1 Week | -0.08% | ||
| 1 Month | -3.93% | ||
| 3 Months | -23.68% | ||
| 1 Year | -46.73% | ||
| 5 Years | N/A |
RXO Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
About rxo inc - RXO
RXO, Inc. engages in providing asset-light transportation solutions. It also offers managed transportation, freight forwarding, and last mile delivery. The company was founded on May 5, 2022 and is headquartered in Charlotte, NC.
RXO At a Glance
RXO, Inc.
11215 North Community House Road
Charlotte, North Carolina 28277
| Phone | 1-980-308-6058 | Revenue | 4.55B | |
| Industry | Packaged Software | Net Income | -290,000,000.00 | |
| Sector | Technology Services | 2024 Sales Growth | 15.865% | |
| Fiscal Year-end | 12 / 2025 | Employees | 9,873 | |
| View SEC Filings |
RXO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.699 |
| Price to Book Ratio | 2.403 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 32.56 |
| Enterprise Value to Sales | 0.837 |
| Total Debt to Enterprise Value | 0.174 |
RXO Efficiency
| Revenue/Employee | 460,852.831 |
| Income Per Employee | -29,373.038 |
| Receivables Turnover | 3.708 |
| Total Asset Turnover | 1.737 |
RXO Liquidity
| Current Ratio | 1.257 |
| Quick Ratio | 1.257 |
| Cash Ratio | 0.033 |
RXO Profitability
| Gross Margin | 15.297 |
| Operating Margin | 0.659 |
| Pretax Margin | -6.681 |
| Net Margin | -6.374 |
| Return on Assets | -11.071 |
| Return on Equity | -26.292 |
| Return on Total Capital | -12.742 |
| Return on Invested Capital | -17.715 |
RXO Capital Structure
| Total Debt to Total Equity | 41.191 |
| Total Debt to Total Capital | 29.174 |
| Total Debt to Total Assets | 19.449 |
| Long-Term Debt to Equity | 35.112 |
| Long-Term Debt to Total Capital | 24.868 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Rxo Inc - RXO
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.69B | 4.80B | 3.93B | 4.55B | |
Sales Growth
| +39.68% | +2.28% | -18.12% | +15.86% | |
Cost of Goods Sold (COGS) incl D&A
| 3.76B | 3.71B | 3.27B | 3.85B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 81.00M | 86.00M | 67.00M | 87.00M | |
Depreciation
| 57.00M | 65.00M | 54.00M | 59.00M | |
Amortization of Intangibles
| 24.00M | 21.00M | 13.00M | 28.00M | |
COGS Growth
| +42.28% | -1.38% | -11.89% | +17.90% | |
Gross Income
| 927.00M | 1.09B | 658.00M | 696.00M | |
Gross Income Growth
| +30.01% | +17.15% | -39.41% | +5.78% | |
Gross Profit Margin
| +19.77% | +22.64% | +16.76% | +15.30% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 731.00M | 866.00M | 591.00M | 666.00M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 731.00M | 866.00M | 591.00M | 666.00M | |
SGA Growth
| +16.22% | +18.47% | -31.76% | +12.69% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 4.00M | 97.00M | 28.00M | 86.00M | |
EBIT after Unusual Expense
| 192.00M | 123.00M | 39.00M | (56.00M) | |
Non Operating Income/Expense
| - | (1.00M) | (3.00M) | (218.00M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | 4.00M | 32.00M | 30.00M | |
Interest Expense Growth
| - | - | +700.00% | -6.25% | - |
Gross Interest Expense
| - | 4.00M | 32.00M | 30.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 191.00M | 119.00M | 4.00M | (304.00M) | |
Pretax Income Growth
| +235.09% | -37.70% | -96.64% | -7,700.00% | |
Pretax Margin
| +4.07% | +2.48% | +0.10% | -6.68% | |
Income Tax
| - | 41.00M | 27.00M | (14.00M) | |
Income Tax - Current - Domestic
| - | 36.00M | 38.00M | 7.00M | |
Income Tax - Current - Foreign
| 2.00M | 9.00M | 1.00M | 5.00M | |
Income Tax - Deferred - Domestic
| 3.00M | (20.00M) | (9.00M) | (17.00M) | |
Income Tax - Deferred - Foreign
| - | - | 1.00M | (2.00M) | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 150.00M | 92.00M | 4.00M | (290.00M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 150.00M | 92.00M | 4.00M | (290.00M) | |
Net Income Growth
| +248.84% | -38.67% | -95.65% | -7,350.00% | |
Net Margin Growth
| +3.20% | +1.92% | +0.10% | -6.37% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 150.00M | 92.00M | 4.00M | (290.00M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 150.00M | 92.00M | 4.00M | (290.00M) | |
EPS (Basic)
| 1.2887 | 0.7904 | 0.0342 | -2.1737 | |
EPS (Basic) Growth
| +248.86% | -38.67% | -95.67% | -6,455.85% | |
Basic Shares Outstanding
| 116.40M | 116.40M | 116.87M | 133.41M | |
EPS (Diluted)
| 1.2887 | 0.7904 | 0.0335 | -2.1737 | |
EPS (Diluted) Growth
| +248.86% | -38.67% | -95.76% | -6,588.66% | |
Diluted Shares Outstanding
| 116.40M | 116.40M | 119.46M | 133.41M | |
EBITDA
| 277.00M | 306.00M | 134.00M | 117.00M | |
EBITDA Growth
| +73.13% | +10.47% | -56.21% | -12.69% | |
EBITDA Margin
| +5.91% | +6.38% | +3.41% | +2.57% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 15.471 | |
| Number of Ratings | 22 | Current Quarters Estimate | -0.043 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 0.173 | |
| Last Quarter’s Earnings | -0.02 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.004 | Next Fiscal Year Estimate | 0.511 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 14 | 20 | 14 |
| Mean Estimate | -0.04 | 0.04 | 0.17 | 0.51 |
| High Estimates | -0.01 | 0.11 | 0.50 | 0.85 |
| Low Estimate | -0.08 | -0.03 | 0.00 | 0.30 |
| Coefficient of Variance | -45.20 | 111.38 | 66.30 | 28.39 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 3 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 15 | 15 | 14 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 2 | 2 | 3 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Rxo Inc - RXO
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Rxo Inc - RXO
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 6, 2025 | Jeffrey D. Firestone Chief Legal Officer | 16,717 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 6, 2025 | Jeffrey D. Firestone Chief Legal Officer | 172,767 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 69,702 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 59,974 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 1,207,876.36 |
| Feb 26, 2025 | James E. Harris Chief Financial Officer | 253,189 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 87,848 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 85,277 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 1,717,478.78 |
| Feb 26, 2025 | Jason S. Kerr Chief Accounting Officer | 10,514 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 223,813 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 188,554 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.14 per share | 3,797,477.56 |
| Feb 26, 2025 | Andrew Wilkerson Chief Executive Officer; Director | 521,637 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Jeffrey D. Firestone Chief Legal Officer | 145,898 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jan 6, 2025 | Bradley S. Jacobs Director | 1,598,436 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jan 6, 2025 | Bradley S. Jacobs Director | 1,054,175 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $23.84 per share | 25,131,532.00 |
| Jan 6, 2025 | Bradley S. Jacobs Director | 8,045 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |